EMP24 Antibody

What are EMP24 family proteins and which antibodies are available for their detection?

The EMP24 family belongs to the p24 protein family involved in protein transport between the endoplasmic reticulum (ER) and Golgi apparatus. These transmembrane proteins, including TMED1 and TMED4 (Transmembrane Emp24 Protein Transport Domain Containing proteins), function in cargo selection and vesicle formation . Multiple antibodies targeting different regions of these proteins are commercially available, including polyclonal antibodies against various amino acid sequences like TMED4 (AA 41-140), TMED4 (Middle Region), and several N-terminal and C-terminal targeting antibodies . These antibodies vary in their host organisms (predominantly rabbit), reactivity profiles across species, and applications, with most supporting Western blotting, immunohistochemistry, and ELISA techniques .

How should I select the appropriate EMP24 antibody for my experimental system?

Antibody selection should be guided by:

• Target species compatibility: Review reactivity profiles carefully, as different antibodies show varying cross-reactivity. For example, ABIN715766 demonstrates reactivity with mouse and rat samples, with predicted reactivity to human, cow, sheep, pig, horse, and rabbit samples .

• Application requirements: Match antibody specifications to your experimental technique. Some antibodies like ABIN715766 support multiple applications including Western Blotting, ELISA, Immunofluorescence, and Immunohistochemistry, while others may have more limited application profiles .

• Target region specificity: Consider which domain of the EMP24 protein you aim to detect. Different antibodies target specific regions (e.g., N-terminal, middle region, C-terminal), which affects detection of various protein forms, fragments, or complexes .

• Validation evidence: Prioritize antibodies with documented validation in your application of interest. For instance, ABIN2776675 was validated using Western Blot with cell lysate as a positive control .

What is the typical cellular localization pattern observed with EMP24 antibodies?

When using immunofluorescence techniques with EMP24 antibodies, researchers typically observe a perinuclear reticular pattern consistent with ER localization, with additional Golgi apparatus staining . This pattern reflects the role of EMP24 proteins in ER-to-Golgi transport. In immunohistochemistry applications, TMED4 antibodies reveal both cytoplasmic and membrane staining patterns, with intensity varying by tissue type and physiological state . For optimal visualization in immunofluorescence applications, both cultured cells (IF (cc)) and paraffin-embedded sections (IF (p)) techniques have been validated for several available antibodies . Confocal microscopy is recommended for co-localization studies with other organelle markers to confirm specific subcellular distributions.

How can EMP24 antibodies be used to investigate cargo selection in ER-to-Golgi transport?

EMP24 antibodies can be employed in several sophisticated approaches to study cargo selection:

• Co-immunoprecipitation studies: Use EMP24 antibodies to identify interacting cargo proteins. Research has demonstrated that the Emp24 complex can be directly cross-linked to specific cargo proteins like Gas1p in yeast, but not to others like Gap1p, suggesting selective cargo recognition .

• Vesicle immunoisolation protocols: Antibodies against the cytosolic tail of Emp24p can immunoisolate ER-derived vesicles, allowing identification of cargo selection patterns. Studies have shown that 83% of Gas1p and 96% of Gap1p copurified with immunoisolated vesicles using anti-Emp24p tail antibodies .

• Inhibition studies: Anti-Emp24p tail antibodies can specifically inhibit the packaging of select cargo (e.g., Gas1p) into COPII-coated vesicles without affecting others (Gap1p, gpαF), providing a tool to study cargo selectivity mechanisms .

What methods are effective for studying EMP24 protein complexes and their interactions?

Advanced methodologies for investigating EMP24 protein complexes include:

• Chemical cross-linking coupled with immunoprecipitation: This approach has successfully demonstrated that Emp24p forms specific complexes with cargo proteins like Gas1p in ER-derived vesicles . The protocol typically involves using chemical cross-linkers such as DSP (dithiobis(succinimidyl propionate)) followed by immunoprecipitation with EMP24 antibodies.

• Blue native PAGE: For analyzing intact protein complexes, blue native PAGE combined with Western blotting using EMP24 antibodies can reveal the composition and size of native complexes. This technique preserves protein-protein interactions and allows for subsequent mass spectrometry analysis of complex components.

• Proximity labeling techniques: BioID or APEX2 fusions with EMP24 proteins, followed by detection with EMP24 antibodies, can identify transient interacting partners in living cells, providing insights into the dynamic interaction network of these transport proteins.

• Super-resolution microscopy: Combining EMP24 antibodies with super-resolution techniques like STORM or PALM enables visualization of EMP24 nanoscale organization within transport vesicles and at ER exit sites, revealing functional clustering that conventional microscopy cannot resolve.

How can genetic manipulation of EMP24 be combined with antibody-based detection to study functional consequences?

Integrating genetic approaches with antibody detection provides powerful insights:

• Mutant phenotype analysis: In yeast studies, emp24 mutants show reduced efficiency (>70% less) in packaging specific cargo proteins like Gas1p into COPII-coated vesicles while not affecting others . EMP24 antibodies can quantify these differences through Western blotting of isolated vesicle fractions.

• Domain-specific mutations: Studies utilizing point mutations (e.g., emp24-E178A) that disrupt antibody recognition but preserve protein function allow for controlled experiments distinguishing between direct and indirect effects of EMP24 proteins on cargo transport . This approach can be particularly useful in structure-function analyses.

• Rescue experiments: Following knockdown or knockout of endogenous EMP24 proteins, expression of tagged or mutant variants followed by detection with specific antibodies allows correlation of structural features with functional recovery in transport assays.

• Tissue-specific or inducible expression systems: Combined with immunohistochemistry using EMP24 antibodies, these systems enable investigation of temporal and spatial requirements for EMP24 function in complex tissues or developmental contexts.

What are the optimal protocols for Western blotting with EMP24 antibodies?

For successful Western blotting with EMP24 antibodies, consider the following optimized protocol:

• Sample preparation:

  • Cell lysis in TEPI buffer (with 1% SDS) at 55°C for 10 minutes has proven effective for solubilizing membrane-associated EMP24 proteins

  • Include protease inhibitors to prevent degradation

  • For membrane proteins like EMP24, avoid boiling samples, which can cause aggregation

• Gel electrophoresis and transfer:

  • 10-12% SDS-PAGE gels typically provide good resolution for EMP24 proteins

  • Use semi-dry transfer systems with PVDF membranes for optimal results with membrane proteins

• Blocking and antibody incubation:

  • Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

  • Incubate with primary antibodies (e.g., ABIN715766, ABIN2776675) at 1:500-1:2000 dilution overnight at 4°C

  • Multiple washing steps (5 × 5 minutes) with TBST are crucial for reducing background

  • Use HRP-conjugated secondary antibodies at 1:5000-1:10000 dilution for 1 hour at room temperature

• Detection:

  • Enhanced chemiluminescence (ECL) substrates provide sufficient sensitivity for most EMP24 detections

  • Quantitative analysis should use PhosphorImager or similar digital imaging systems

What are the critical factors for successful immunoprecipitation with EMP24 antibodies?

Successful immunoprecipitation of EMP24 proteins requires attention to several critical factors:

• Detergent selection: Use mild non-ionic detergents (0.5-1% NP-40 or Triton X-100) to preserve protein-protein interactions. For studying membrane-embedded EMP24 proteins, digitonin (0.5-1%) may better preserve native complexes.

• Buffer composition: Include 150mM NaCl, 50mM Tris-HCl (pH 7.4), and protease inhibitors. For cross-linking studies, 2-mercaptoethanesulfonic acid can replace dithiothreitol as used in published protocols .

• Antibody binding conditions: Pre-clear lysates with protein A/G beads before adding EMP24 antibodies to reduce non-specific binding. Incubate antibodies with lysates (4°C, overnight) for optimal antigen capture.

• Elution strategies: For non-denaturing elution, competitive elution with the immunizing peptide can preserve complex integrity. For stringent conditions, use 1% SDS in TEPI buffer (55°C, 10 minutes) as documented in research protocols .

• Controls: Always include isotype controls and, when possible, samples from knockout/knockdown systems to validate specificity.

What considerations are important for immunohistochemistry and immunofluorescence with EMP24 antibodies?

For optimal immunohistochemistry and immunofluorescence results:

• Fixation methods:

  • For cultured cells: 4% paraformaldehyde (10-15 minutes) preserves antigenicity while maintaining structure

  • For tissue sections: 10% neutral buffered formalin followed by paraffin embedding works well with most EMP24 antibodies

• Antigen retrieval:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0) is generally effective

  • For paraffin sections, combined pressure and heat treatment may improve signal

• Antibody dilution and incubation:

  • For IHC applications, dilutions of 1:50-1:200 are typically effective

  • Longer incubation times (overnight at 4°C) often yield better signal-to-noise ratios than short incubations

  • The ABIN715766 antibody has been validated for multiple immunofluorescence applications including cultured cells (IF (cc)) and paraffin-embedded sections (IF (p))

• Controls and counterstaining:

  • Use DAPI or hematoxylin for nuclear counterstaining

  • Include absorption controls with immunizing peptide to confirm specificity

• Dual labeling considerations:

  • For co-localization studies, pair EMP24 antibodies with markers for ER (calnexin), ERGIC (ERGIC-53), or Golgi (GM130) compartments

  • Select secondary antibodies with minimal cross-reactivity and spectrally distinct fluorophores

How can I address weak or absent signals when using EMP24 antibodies?

Systematic troubleshooting for signal issues includes:

• Sample preparation problems:

  • Ensure proper protein extraction, especially for membrane proteins like EMP24

  • Avoid repeated freeze-thaw cycles of samples

  • Verify protein concentration using reliable assays compatible with detergent-containing buffers

• Antibody-related factors:

  • Confirm antibody reactivity with your species of interest (check predicted reactivity data)

  • Consider epitope accessibility in your experimental system

  • Test increased antibody concentration or longer incubation times

  • Verify antibody functionality with positive control samples

• Detection limitations:

  • For low abundance targets, consider signal amplification systems like tyramide signal amplification

  • Ensure appropriate exposure times for Western blots

  • For fluorescence applications, minimize photobleaching during imaging

• Protocol optimization:

  • Revise blocking conditions (type and concentration of blocking agent)

  • Adjust detergent concentration in washing steps

  • For IHC/IF, optimize antigen retrieval methods (heat, enzymatic, or pH adjustments)

What approaches can resolve specificity concerns with EMP24 antibodies?

To address specificity issues:

• Validation controls:

  • Use knockout/knockdown samples as negative controls

  • Compare staining patterns with multiple antibodies targeting different epitopes of the same protein

  • Perform peptide competition assays with the immunizing peptide

• Cross-reactivity assessment:

  • Test antibodies on samples from species with known sequence differences

  • Verify band size in Western blots against predicted molecular weight

  • Consider using more specific monoclonal antibodies if available

• Genetic verification approaches:

  • Express tagged versions of the protein for dual detection (e.g., detect both the tag and the protein)

  • Use point mutations that affect antibody binding without altering protein function, as demonstrated with the emp24-E178A mutant

• Alternative detection strategies:

  • Complement antibody-based detection with functional assays

  • Consider mass spectrometry analysis of immunoprecipitated material

How can discrepancies between immunofluorescence patterns and biochemical fractionation results be reconciled?

Resolving discrepancies between techniques requires systematic investigation:

• Methodological differences:

  • Fixation methods may alter epitope accessibility or protein localization

  • Biochemical fractionation may disrupt protein complexes or cause artificial redistribution

  • Different antibodies may recognize different forms or conformations of the protein

• Analytical approaches:

  • Conduct subcellular fractionation followed by Western blotting with the same antibody used for immunofluorescence

  • Use membrane extraction methods with increasing detergent strengths to distinguish integral from peripheral membrane associations

  • Perform density gradient separation of organelles for more precise localization

• Complementary techniques:

  • Employ live cell imaging with fluorescently tagged EMP24 proteins

  • Use proximity labeling methods (BioID, APEX) to confirm localizations biochemically

  • Perform electron microscopy with immunogold labeling for highest resolution localization

• Controls and validation:

  • Include markers for specific compartments in both approaches

  • Consider cell cycle or condition-dependent localization changes

  • Validate with orthogonal methods like proximity ligation assays

How might emerging technologies enhance EMP24 antibody applications in research?

Emerging technologies offer new possibilities for EMP24 research:

• Advanced microscopy techniques:

  • Super-resolution microscopy methods (STORM, PALM, STED) combined with EMP24 antibodies can reveal nanoscale organization and dynamics of transport intermediates

  • Lattice light-sheet microscopy enables long-term, high-resolution imaging of EMP24-positive structures with minimal phototoxicity

  • Expansion microscopy physically enlarges specimens, potentially revealing details of EMP24 distribution undetectable by conventional microscopy

• Multiplexed detection systems:

  • Mass cytometry (CyTOF) with metal-conjugated EMP24 antibodies allows simultaneous detection of dozens of markers

  • Iterative immunofluorescence methods enable detection of 40+ proteins on the same sample

  • Spatial transcriptomics combined with protein detection can correlate EMP24 localization with local gene expression patterns

• Proteomics integration:

  • Proximity labeling approaches (BioID, APEX2) can identify the EMP24 interactome under various conditions

  • Cross-linking mass spectrometry can map interaction surfaces between EMP24 and cargo molecules or coat proteins

  • Targeted proteomics using internal standard peptides enables absolute quantification of EMP24 proteins in different cellular compartments

What are promising research areas for investigating EMP24 function using antibody-based techniques?

High-potential research directions include:

• Disease-specific studies:

  • Investigation of EMP24 family proteins in neurodegenerative diseases where ER-Golgi transport is compromised

  • Analysis of EMP24 expression and localization in cancer progression and metastasis

  • Examination of EMP24 roles in immune cell function and protein secretion pathways

• Developmental biology applications:

  • Tracking EMP24 expression patterns during differentiation using developmental stage-specific samples

  • Investigating tissue-specific functions through comparative immunohistochemistry

  • Exploring roles in morphogen trafficking during embryogenesis

• Stress response investigations:

  • Analysis of EMP24 behavior during ER stress and unfolded protein response

  • Characterization of post-translational modifications of EMP24 proteins under stress conditions

  • Investigation of EMP24 complex remodeling during cellular adaptation to changing environments

• Therapeutic targeting studies:

  • Development of inhibitory antibodies against specific EMP24 domains for functional studies

  • Investigation of EMP24 as a biomarker for secretory pathway dysfunction

  • Analysis of EMP24 involvement in drug and toxin sensitivity

How can computational approaches enhance the use of EMP24 antibodies in research?

Computational methods offer significant enhancements:

• Epitope prediction and antibody design:

  • In silico prediction of optimal epitopes based on structural models of EMP24 proteins

  • Structure-based antibody design for increased specificity and affinity

  • Computational screening of antibody variants for improved performance

• Image analysis automation:

  • Machine learning algorithms for automated quantification of EMP24 staining patterns

  • Deep learning approaches for detecting subtle changes in subcellular localization

  • Computer vision methods for tracking dynamic changes in EMP24-positive structures

• Systems biology integration:

  • Network analysis of EMP24 interactions identified through antibody-based techniques

  • Predictive modeling of cargo selection based on EMP24 binding determinants

  • Multi-omics data integration to place EMP24 function in broader cellular contexts

• Database development:

  • Creation of standardized antibody validation repositories for EMP24 family proteins

  • Integration of staining patterns across tissues, conditions, and species

  • Development of reference atlases for normal versus pathological EMP24 distribution patterns

How do different fixation and permeabilization methods affect EMP24 antibody staining patterns?

Different methods have distinct impacts on EMP24 detection:

For permeabilization, Triton X-100 (0.1-0.2%) is generally effective for EMP24 detection in immunofluorescence applications, while saponin (0.1%) offers gentler permeabilization that better preserves membrane structures .

What are the comparative advantages of monoclonal versus polyclonal EMP24 antibodies?

Understanding these differences is critical for experimental design:

Most available EMP24 antibodies are polyclonal, such as those produced in rabbits against specific amino acid sequences (e.g., AA 41-140, Middle Region) , offering good versatility across applications but requiring thorough validation to ensure specificity.

What strategies can optimize detection of low-abundance EMP24 proteins in complex samples?

For enhanced detection of low-abundance targets:

• Sample enrichment techniques:

  • Subcellular fractionation to concentrate ER/Golgi membranes

  • Immunoprecipitation before Western blotting

  • Density gradient centrifugation of vesicle preparations

• Signal amplification methods:

  • Tyramide signal amplification for immunohistochemistry

  • Enhanced chemiluminescence substrates for Western blotting

  • Quantum dot-conjugated secondary antibodies for brighter, photostable fluorescence

• Instrumentation optimization:

  • CMOS or EM-CCD cameras for low-light fluorescence imaging

  • Confocal microscopy with photomultiplier tube detectors

  • Digital accumulation over multiple exposures for Western blot detection

• Protocol modifications:

  • Extended primary antibody incubation (overnight at 4°C)

  • Reduced washing stringency (lower detergent concentration)

  • Optimized blocking to reduce background while preserving specific signal